Phibro Animal Health Co. (NASDAQ:PAHC – Free Report) – Analysts at Zacks Research lifted their FY2025 EPS estimates for shares of Phibro Animal Health in a report issued on Wednesday, March 12th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $1.91 per share for the year, up from their previous forecast of $1.87. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share.
Phibro Animal Health (NASDAQ:PAHC – Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%.
Read Our Latest Research Report on PAHC
Phibro Animal Health Price Performance
Phibro Animal Health stock opened at $21.25 on Monday. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The company’s fifty day moving average price is $22.57 and its 200 day moving average price is $22.59. The stock has a market capitalization of $860.69 million, a P/E ratio of 44.27, a P/E/G ratio of 0.45 and a beta of 0.58. Phibro Animal Health has a 1 year low of $12.05 and a 1 year high of $26.55.
Phibro Animal Health Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.26%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 100.00%.
Hedge Funds Weigh In On Phibro Animal Health
Several large investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its position in Phibro Animal Health by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 1,514,736 shares of the company’s stock valued at $31,809,000 after purchasing an additional 20,604 shares during the period. American Century Companies Inc. lifted its stake in Phibro Animal Health by 18.0% during the 4th quarter. American Century Companies Inc. now owns 635,599 shares of the company’s stock worth $13,348,000 after acquiring an additional 96,787 shares in the last quarter. Nuveen Asset Management LLC grew its position in Phibro Animal Health by 21.4% in the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company’s stock valued at $12,348,000 after acquiring an additional 103,618 shares in the last quarter. Renaissance Technologies LLC increased its stake in Phibro Animal Health by 1.9% during the fourth quarter. Renaissance Technologies LLC now owns 557,800 shares of the company’s stock worth $11,714,000 after purchasing an additional 10,600 shares during the period. Finally, Geode Capital Management LLC lifted its position in shares of Phibro Animal Health by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 515,979 shares of the company’s stock worth $10,838,000 after purchasing an additional 8,510 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.
About Phibro Animal Health
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Recommended Stories
- Five stocks we like better than Phibro Animal Health
- How to Invest in the FAANG Stocks
- How to Build the Ultimate Everything ETF Portfolio
- Investing in Commodities: What Are They? How to Invest in Them
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Roth IRA Calculator: Calculate Your Potential Returns
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.